Continuous Molecular Monitoring for Precision Heart Failure Care:
Heart failure (HF) remains a critical public health concern, with readmission rates contributing significantly to the clinical and economic burden of the disease. Nearly 1 in 4 HF patients are readmitted within 30 days of discharge, and approximately one-half are readmitted within 6 months. 1 Current care strategies, which primarily rely on periodic clinical evaluations, patient-reported symptoms, and intermittent laboratory draws, often fail to detect the early physiological changes in HF that can
